A shared story by Holly Payne argues there is very little data on who is using peptides nationwide and how.
Recap by typeshit. Post by Facebook on Facebook.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
Robin Hough talks with his mother and a nurse practitioner about weight lost, side effects like nausea and hair loss, and how coverage can stop at goal weight.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
Loading…